Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057821/0/en/Cerevance-Presents-Positive-Results-from-Phase-1-Study-of-CVN293-at-American-Academy-of-Neurology-2025-Annual-Meeting.html
01 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/01/3053340/0/en/Cerevance-Presents-Topline-Results-from-Phase-2-ASCEND-Trial-of-Solengepras-as-Monotherapy-Treatment-for-Early-Stage-Parkinson-s-Disease-at-AD-PD-2025.html
01 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/cerevance-fails-phase-2-trial-early-untreated-parkinsons
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050466/0/en/New-Data-to-Be-Presented-at-Upcoming-Congresses-Showcase-Cerevance-s-Advanced-Clinical-Program-in-Parkinson-s-Disease-and-Deep-Pipeline-for-CNS-based-Disorders.html
18 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/18/2982801/0/en/Cerevance-Doses-First-Patient-in-Pivotal-Phase-3-ARISE-Trial-of-Solengepras-for-Treatment-of-Parkinson-s-Disease.html
11 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/11/2978299/0/en/Cerevance-s-CVN293-Demonstrated-Positive-Phase-1-Results-in-Healthy-Volunteers.html
ABOUT THIS PAGE